TNXP filings
Corporate insider profile
Seth Lederman Filing Activity
Latest reported as Chief Executive Officer of Tonix Pharmaceuticals Holding Corp. (TNXP).
- Purchase filings
- 1
- Reported companies
- 1
- Net open-market value
- $58,950
- Latest transaction
- Jun 9, 2026
Affiliated corporations
Reported company relationships
Transaction history